Navigation Links
Cerno Bioscience Introduces MassWorks AutoID for Fully Automated Quadrupole MS Formula Determination
Date:2/16/2011

DANBURY, Conn., Feb. 16, 2011 /PRNewswire/ -- Cerno Bioscience today announces the successful test installation and operation of a new software product, MassWorks AutoID™, at a major pharmaceutical company near Boston, MA.  By automating the patented MassWorks calibration and formula ID process on the widely available quadrupole MS systems, AutoID makes the 100x improvement in mass accuracy and the unparallel Spectral Accuracy available seamlessly and at all times.  With both accurate mass and high Spectral Accuracy, AutoID allows any user to either confirm a given formula or propose possible formulas in a fully automated fashion without any human intervention or manual operation.

Built on top of its award-winning MassWorks software, AutoID completely removes the manual steps involved in MassWorks, such as the injection of a calibration standard, the user selection of ions and parameters for elemental composition determination, and the report generation/delivery.  For highly automated applications such as Open Access, AutoID not only brings the formula ID capability to non-expert MS users including synthetic organic or medicinal chemists but also reduces the burden of analytical chemists or mass spectrometrists supporting these functions.

Mr. Hongliang (Leo) Xu, Software Development Manager comments: "The AutoID project is our very first effort at taking the modular components from MassWorks to build new and dedicated applications.  We succeeded by completing this first installation in record time and thus paved the way for more exciting new products to come."  Dr. Yongdong Wang, President of Cerno Bioscience adds: "We built MassWorks with expert MS users in mind and have been very successful at marketing it to hundred of these users around the world.  By making the formula ID capability available seamlessly to non-expert users on a quadrupole system, we can realize significant savings in time, effort, and hardware expenditure for our customers.  While we will continue to enhance and maintain MassWorks software as an industry-leading research tool, AutoID represents the start of our endeavor at introducing automated and dedicated new products to address the broader market needs.  Our goal is to make MassWorks calibration technology and Spectral Accuracy available to every MS user."

To learn more about the concept of Spectral Accuracy, see this front cover feature article in Analytical Chemistry (http://pubs.acs.org/doi/full/10.1021/ac100888b).

For more information on Cerno Bioscience, MassWorks, or AutoID, please email info@cernobioscience.com, call +1 203-312-1150, or visit www.cernobioscience.com.  

About Cerno BioscienceCerno is dedicated to the practical application of modern mathematical techniques to Mass Spectrometry for the purpose of improving the quality, accuracy and reliability of MS analysis. These techniques can be used to dramatically improve the amount of information obtainable from and reduce the amount of time required of many MS experiments. Cerno's technologies are proprietary and protected through numerous patents granted and submitted world-wide. For more information on Cerno MS technologies, applications, or products please visit our Web site: www.cernobioscience.com.

About Cerno Bioscience ProductsCerno Bioscience's MassWorks family of software products performs post-acquisition MS calibration and formula determination through either CLIPS at unit mass resolution or sCLIPS at higher resolution.  It supports all major MS vendor data formats and works with all MS instruments including GC/MS, LC/MS, TOF, qTOF, and FT MS. Cerno Bioscience products are used in major R&D labs for pharmaceuticals, food, beverages, flavors, fragrances, natural products, environmental analysis, forensics, fine chemicals and petrochemicals. For more information, please visit: http://www.cernobioscience.com/products.html.

Copyright 2011. Cerno Bioscience LLC. All rights reserved. Cerno Bioscience is a registered trademark and MassWorks, CLIPS, and sCLIPS are trademarks of Cerno Bioscience.  Media Contact:Yongdong WangCerno Bioscience+1 203-312-1151pr@cernobioscience.com
'/>"/>

SOURCE Cerno Bioscience
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Neurocrine Biosciences Reports Fourth Quarter and Year End 2010 Results
2. YM BioSciences Reports Fiscal Second Quarter 2011 Operational and Financial Results
3. Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results
4. Sangamo BioSciences Announces Fourth Quarter and Full Year 2010 Conference Call and Webcast
5. Centroid Wins a 2-Year Infrastructure Outsourcing Services Contract with eBioscience
6. YM BioSciences Announces Data from Nimotuzumab Phase II Gastric Cancer Trial Reported at ASCO GI Symposium
7. Ardea Biosciences Prices Public Offering of Common Stock
8. Ardea Biosciences Announces Positive Top-Line Results from Phase 2b Combination Study of RDEA594 in Allopurinol-Refractory Gout Patients
9. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
10. Whitney M. Young, Jr. Health Services and Magellan Biosciences Partner to Provide Three-Minute LeadCare II Blood-Lead Screenings to Berlin Elementary Students
11. YM BioSciences Closes Public Offering of Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... In starting a program to hire college athletes, Catalyst COO ... skill.” , In keeping with this philosophy, the Catalyst an Iowa premix manufacturer recently ... to replicate the practice throughout the company. , “I’ve heard coaches talk on television ...
(Date:2/25/2017)... ... February 25, 2017 , ... The ... in an ongoing effort to create meaningful change by increasing communication, partnerships and ... emphasis on consumers and patients’ mental health well-being. , Both organizations are dedicated ...
(Date:2/24/2017)... San Diego, Calif. (PRWEB) , ... February 24, 2017 , ... ... African food and wine scene. Making stops in several cities, she gained a ... Her culinary adventure began in Stellenbosch, a town in South Africa’s Western Cape province. ...
(Date:2/24/2017)... Feb. 24, 2017 Symic Bio, a biopharmaceutical ... new category of therapeutics, announced today the completion of ... peripheral artery disease. The trial will evaluate the safety ... in the reduction of restenosis following angioplasty. ... milestone for SB-030," said Nathan Bachtell , M.D., ...
Breaking Biology Technology:
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):